Glucuronolactone Market By Type (Powder, Liquid, Tablet/Capsule), By Application (Preservatives, Antioxidants, Processing Aids and Additives, Energy Supplements), By End User (Food and Beverages, Pharmaceuticals): Global Opportunity Analysis and Industry Forecast, 2023-2032

Glucuronolactone Market

The organic metabolite glucuronolactone, also known as "D-glucuronolactone" or "D-glucuronic acid," is present in the body. This odorless solid white substance is a significant element in energy drinks and stimulants like Red Bull. Glucuronolactone is a naturally occurring chemical compound found in connective tissues such as animal and human cartilage, ligaments, and tendons. The substance is also generated from plant gums and is classified as a glucuronic acid lactone.

Glucuronolactone is used as one of the main ingredients in various energy drinks and supplements owing to its various benefits. Integration of IoT, ML, and AI technology in medical processes and equipment drives market development. These technologies have brought about significant improvements in various aspects of healthcare, including patient care, diagnostics, treatment, and operational efficiency. IoT, ML, and AI have contributed to the growth of the medical industry by aiding remote patient monitoring, personalized medicine, data security and privacy. Furthermore, increased chronic disease occurrences, as well as a growing geriatric population, are contributing to overall market growth. The widespread use of glucuronolactone in the food and beverage industries, such as in curing, pickling, and leavening agent, is expected to drive market expansion. Furthermore, the widespread use of home care settings, point-of-care diagnostics, and increased awareness of glucuronolactone in prescription medications for treating bone disease, hepatitis, and collagen disease are predicted to drive market expansion during the projection period.

However, glucuronolactone-based drugs may cause anxiety, insomnia, muscle twitching, or an increase in heart rate, which can be dangerous to people with high blood pressure. The safest amount of glucuronolactone supplementation is 500 to 600 mg per day. When used in large quantities, it might produce headaches, stomach cramps, and irritation. Furthermore, it might cause aggressive behavior and insomnia, which are expected to hinder market growth.

The glucuronolactone industry is expanding due to the increasing investments in the pharmaceutical industry. This can be due to the growing use of glucuronolactone in the manufacture of medicines, where it is used as a stabilizer and for other purposes. Additionally, the overall market is expanding as a result of the increased prevalence of chronic diseases and the rising elderly population. Additionally, it is anticipated that the widespread use of glucuronolactone in the food and beverage industry, such as in curing, pickling, and leavening agent, will support market expansion. Furthermore, it is predicted that the demand for glucuronolactone will expand throughout the forecast period due to rising health consciousness and increased interest in enhancing physical fitness. Additionally, Hubei Yitai Pharmaceutical Co., Ltd offers glucuronolactone used as a food additive, which is widely used in health foods and functional beverages. The product regulates immune function, anti-aging, moistening skin, improving oxygen to the brain, and helps in recovering from fatigue. All these factors are predicted to create an excellent opportunity for market growth during the forecast period.

The glucuronolactone market share is segmented on the basis of type, application, end use, and region. By type, it is classified into powder, liquid, and tablet & capsule. By application, it is classified into preservatives, antioxidants, processing aids & additives, energy supplements, and others. By end user. It is classified into food & beverages, pharmaceuticals, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players profiled in the glucuronolactone market report include Anhui Fubore Pharmaceutical & Chemical Co.Ltd., Hubei Yitai Pharmaceutical Co.Ltd., Shandong Fuyuan Bio-Tech CO.LTD., Shandong Baisheng Biotechnology Co., Ltd., Functional Food chem International Corporation, Shaoxing Marina Biotechnology Co.Ltd., Merck Millipore Corporation, Jungbunzlauer, Shandong Xinhong Pharmaceutical Co., Ltd., and Roquette Frères.

The report offers a comprehensive analysis of the global glucuronolactone market trends by thoroughly studying different aspects of the market including major segments, market statistics, market dynamics, regional market outlook, investment opportunities, and top players working towards the growth of the market. The report also highlights on the present scenario and upcoming trends & developments that are contributing toward the growth of the market. Moreover, restraints and challenges that hold power to obstruct the market growth are also profiled in the report along with the Porter’s five forces analysis of the market to elucidate factors such as competitive landscape, bargaining power of buyers and suppliers, threats of new players, and emergence of substitutes in the market.

Impact of COVID-19 on the Global Glucuronolactone Industry

Initially, COVID-19 led to disruptions in supply chains, manufacturing, and distribution, which led to challenges in sourcing raw materials and maintaining production levels. Lockdowns and reduced economic activity also impacted consumer spending on dietary supplements and related products, affecting the demand.

The pandemic underscored the importance of health and immunity, interest in supplements like glucuronolactone, known for potential cognitive and energy-enhancing benefits, grew. The shift towards remote work and focus on personal well-being contributed to this trend. Manufacturers adapted by emphasizing online sales channels and promoting the immune-boosting aspects of their products, aiding industry recovery.

In the post-COVID-19 pandemic, the glucuronolactone market is expected to undergo several changes. With an increased focus on health and well-being, there could be a surge in demand for dietary supplements and functional ingredients like glucuronolactone, as consumers seek products that support their immune systems and overall health.

Key Findings of the Study

Based on type, the liquid sub-segment emerged as the global leader in 2022 and powder sub-segment is anticipated to be the fastest growing sub-segment during the forecast period.

Based on application, the antioxidants sub-segment emerged as the global leader in 2022 and energy supplements sub-segment is predicted to show the fastest growth in the upcoming years.

Based on end user, the pharmaceuticals sub-segment emerged as the global leader in 2022 and food & beverages sub-segment is predicted to show the fastest growth in the upcoming years.

Based on region, the North America market registered the highest market share in 2022 and Asia-Pacific is predicted to show the fastest growth in the upcoming years.

Overview

The global glucuronolactone market is anticipated to reach $6,17,293.3 thousand by 2032, growing from $3,80,308.6 thousand in 2022 at a CAGR of 5.2% from 2023 to 2032.

Glucuronolactone is a chemical found in food products and is also manufactured in laboratories. Glucuronolactone is used as an ingredient in various consumer products, including some energy drinks, dietary supplements, and functional beverages... Glucuronolactone is included in supplements alongside taurine and caffeine. It can also be used in conjunction with other pre-workout substances like as creatine, beta-alanine, and citrulline. Glucuronolactone is a common ingredient found in many energy drinks such as Red bull and a number of pre-workout supplements, and fat-loss proteins, and it is found to increase bodily strength and intellectual focus.

A growing sedentary lifestyle and consumption of an unhealthy diet are driving market growth. The increasing demand for immediate energy-releasing products such as Rockstar, Red Bull, and Monster has contributed to market expansion. Furthermore, increased demand for clean-label and plant-based goods, as well as a growing inclination for a healthy, active lifestyle, are predicted to drive market expansion throughout the projection period. Furthermore, the increased usage of social media platforms such as Instagram and YouTube by manufacturers to advertise sports items is likely to drive market expansion throughout the forecast period by increasing the popularity of products. Moreover, the increasing disposable income of the consumers, and rising focus on sports nutrition encourage new product development, coupled with the rising awareness of sports nutrition.

The high glucuronolactone prices and different adverse impacts of excessive glucuronolactone intake, like disorientation, dizziness, and fast heartbeat, are expected to hamper market growth. The regulatory landscape surrounding dietary supplements and functional ingredients like glucuronolactone is evolving. Governments and regulatory bodies are placing greater emphasis on safety, efficacy, and accurate labeling. As regulations become more stringent, companies operating in the glucuronolactone market might face challenges in obtaining the necessary approvals and certifications for their products. These regulatory hurdles can lead to delays in product launches and additional costs associated with compliance, hindering the growth prospects of the market.

Rising pharmaceutical investments are contributing to the glucuronolactone industry's expansion. This can be due to the growing use of glucuronolactone in medicine manufacture, where it is employed as an addition to preserve uniformity and other properties. Rising innovation by key companies in glucuronolactone is expected to drive market growth. For instance, on 28 March 2019, to compete directly with market leaders Coca Cola launched its first energy drink in the United Kingdom, driving demand for glucuronolactone. The new drink, which contains caffeine, glucuronolactone, guarana extracts, and B vitamins, is intended for those aged 18 to 35.

The COVID-19 pandemic has had significant impacts on the market for glucuronolactone, influencing various aspects of its dynamics. Supply chain disruptions emerged as a significant challenge, with lockdowns, restrictions on travel, and reduced workforce availability affecting the sourcing of raw materials necessary for glucuronolactone production. These disruptions, combined with manufacturing facility closures and reduced operational capacities due to health and safety protocols, led to production slowdowns and potential shortages of glucuronolactone-containing products. The pandemic-induced shift in consumer behavior towards health and wellness further influenced the demand for dietary supplements and functional ingredients like glucuronolactone. With consumers increasingly seeking products that support immunity and overall well-being, the market experienced fluctuations in demand. Additionally, the closure of physical retail outlets prompted a greater reliance on online sales channels for distributing products, accelerating the trend towards e-commerce within the industry.

The key players profiled in this report include Anhui Fubore Pharmaceutical & Chemical Co.Ltd., Hubei Yitai Pharmaceutical Co.Ltd., Shandong Fuyuan Bio-Tech CO.LTD., Shandong Baisheng Biotechnology Co., Ltd., Functional Food chem International Corporation, Shaoxing Marina Biotechnology Co.Ltd., Merck Millipore Corporation, Jungbunzlauer, Shandong Xinhong Pharmaceutical Co., Ltd., Roquette Frères. The market players are continuously striving to achieve an upper hand in this competitive market using strategies such as collaborations and acquisitions.

Key Benefits For Stakeholders

●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the glucuronolactone market analysis from 2022 to 2032 to identify the prevailing glucuronolactone market opportunities.

●The market research is offered along with information related to key drivers, restraints, and opportunities.

●Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

●In-depth analysis of the glucuronolactone market segmentation assists to determine the prevailing market opportunities.

●Major countries in each region are mapped according to their revenue contribution to the global market.

●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

●The report includes the analysis of the regional as well as global glucuronolactone market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

● Quarterly Update and* (only available with a corporate license, on listed price)

● 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.

● Free Upcoming Version on the Purchase of Five and Enterprise User License.

● 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)

● 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)

● Free data Pack on the Five and Enterprise User License. (Excel version of the report)

● Free Updated report if the report is 6-12 months old or older.

● 24-hour priority response*

● Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

● Investment Opportunities

● Supply Chain Analysis & Vendor Margins

● Technology Trend Analysis

● Consumer Preference and Product Specifications

○ Anhui Fubore Pharmaceutical & Chemical Co.Ltd

Scope of Glucuronolactone Market Report

1.1. Report description

1.2. Key market segments

1.3. Key benefits to the stakeholders

1.4. Research Methodology

1.4.1. Primary research

1.4.2. Secondary research

1.4.3. Analyst tools and models

2.1. CXO Perspective

3.1. Market definition and scope

3.2. Key findings

3.2.1. Top impacting factors

3.2.2. Top investment pockets

3.3. Porter’s five forces analysis

3.4. Market dynamics

3.4.1. Drivers

3.4.2. Restraints

3.4.3. Opportunities

3.5. Average Selling Price

3.6. Market Share Analysis

3.7. Brand Share Analysis

3.8. Trade Data Analysis

3.9. Product Consumption

3.10. Value Chain Analysis

3.11. Regulatory Guidelines

3.12. Key Regulation Analysis

3.13. Reimbursement Scenario

3.14. Patent Landscape

4.1. Overview

4.1.1. Market size and forecast

4.2. Powder

4.2.1. Key market trends, growth factors and opportunities

4.2.2. Market size and forecast, by region

4.2.3. Market share analysis by country

4.3. Liquid

4.3.1. Key market trends, growth factors and opportunities

4.3.2. Market size and forecast, by region

4.3.3. Market share analysis by country

4.4. Tablet/Capsule

4.4.1. Key market trends, growth factors and opportunities

4.4.2. Market size and forecast, by region

4.4.3. Market share analysis by country

5.1. Overview

5.1.1. Market size and forecast

5.2. Preservatives

5.2.1. Key market trends, growth factors and opportunities

5.2.2. Market size and forecast, by region

5.2.3. Market share analysis by country

5.3. Antioxidants

5.3.1. Key market trends, growth factors and opportunities

5.3.2. Market size and forecast, by region

5.3.3. Market share analysis by country

5.4. Processing Aids and Additives

5.4.1. Key market trends, growth factors and opportunities

5.4.2. Market size and forecast, by region

5.4.3. Market share analysis by country

5.5. Energy Supplements

5.5.1. Key market trends, growth factors and opportunities

5.5.2. Market size and forecast, by region

5.5.3. Market share analysis by country

6.1. Overview

6.1.1. Market size and forecast

6.2. Food and Beverages

6.2.1. Key market trends, growth factors and opportunities

6.2.2. Market size and forecast, by region

6.2.3. Market share analysis by country

6.3. Pharmaceuticals

6.3.1. Key market trends, growth factors and opportunities

6.3.2. Market size and forecast, by region

6.3.3. Market share analysis by country

7.1. Overview

7.1.1. Market size and forecast By Region

7.2. North America

7.2.1. Key market trends, growth factors and opportunities

7.2.2. Market size and forecast, by Type

7.2.3. Market size and forecast, by Application

7.2.4. Market size and forecast, by End User

7.2.5. Market size and forecast, by country

7.2.5.1. U.S.

7.2.5.1.1. Market size and forecast, by Type

7.2.5.1.2. Market size and forecast, by Application

7.2.5.1.3. Market size and forecast, by End User

7.2.5.2. Canada

7.2.5.2.1. Market size and forecast, by Type

7.2.5.2.2. Market size and forecast, by Application

7.2.5.2.3. Market size and forecast, by End User

7.2.5.3. Mexico

7.2.5.3.1. Market size and forecast, by Type

7.2.5.3.2. Market size and forecast, by Application

7.2.5.3.3. Market size and forecast, by End User

7.3. Europe

7.3.1. Key market trends, growth factors and opportunities

7.3.2. Market size and forecast, by Type

7.3.3. Market size and forecast, by Application

7.3.4. Market size and forecast, by End User

7.3.5. Market size and forecast, by country

7.3.5.1. Germany

7.3.5.1.1. Market size and forecast, by Type

7.3.5.1.2. Market size and forecast, by Application

7.3.5.1.3. Market size and forecast, by End User

7.3.5.2. UK

7.3.5.2.1. Market size and forecast, by Type

7.3.5.2.2. Market size and forecast, by Application

7.3.5.2.3. Market size and forecast, by End User

7.3.5.3. France

7.3.5.3.1. Market size and forecast, by Type

7.3.5.3.2. Market size and forecast, by Application

7.3.5.3.3. Market size and forecast, by End User

7.3.5.4. Spain

7.3.5.4.1. Market size and forecast, by Type

7.3.5.4.2. Market size and forecast, by Application

7.3.5.4.3. Market size and forecast, by End User

7.3.5.5. Italy

7.3.5.5.1. Market size and forecast, by Type

7.3.5.5.2. Market size and forecast, by Application

7.3.5.5.3. Market size and forecast, by End User

7.3.5.6. Rest of Europe

7.3.5.6.1. Market size and forecast, by Type

7.3.5.6.2. Market size and forecast, by Application

7.3.5.6.3. Market size and forecast, by End User

7.4. Asia-Pacific

7.4.1. Key market trends, growth factors and opportunities

7.4.2. Market size and forecast, by Type

7.4.3. Market size and forecast, by Application

7.4.4. Market size and forecast, by End User

7.4.5. Market size and forecast, by country

7.4.5.1. China

7.4.5.1.1. Market size and forecast, by Type

7.4.5.1.2. Market size and forecast, by Application

7.4.5.1.3. Market size and forecast, by End User

7.4.5.2. Japan

7.4.5.2.1. Market size and forecast, by Type

7.4.5.2.2. Market size and forecast, by Application

7.4.5.2.3. Market size and forecast, by End User

7.4.5.3. India

7.4.5.3.1. Market size and forecast, by Type

7.4.5.3.2. Market size and forecast, by Application

7.4.5.3.3. Market size and forecast, by End User

7.4.5.4. South Korea

7.4.5.4.1. Market size and forecast, by Type

7.4.5.4.2. Market size and forecast, by Application

7.4.5.4.3. Market size and forecast, by End User

7.4.5.5. Australia

7.4.5.5.1. Market size and forecast, by Type

7.4.5.5.2. Market size and forecast, by Application

7.4.5.5.3. Market size and forecast, by End User

7.4.5.6. Rest of Asia-Pacific

7.4.5.6.1. Market size and forecast, by Type

7.4.5.6.2. Market size and forecast, by Application

7.4.5.6.3. Market size and forecast, by End User

7.5. LAMEA

7.5.1. Key market trends, growth factors and opportunities

7.5.2. Market size and forecast, by Type

7.5.3. Market size and forecast, by Application

7.5.4. Market size and forecast, by End User

7.5.5. Market size and forecast, by country

7.5.5.1. Brazil

7.5.5.1.1. Market size and forecast, by Type

7.5.5.1.2. Market size and forecast, by Application

7.5.5.1.3. Market size and forecast, by End User

7.5.5.2. Saudi Arabia

7.5.5.2.1. Market size and forecast, by Type

7.5.5.2.2. Market size and forecast, by Application

7.5.5.2.3. Market size and forecast, by End User

7.5.5.3. United Arab Emirates

7.5.5.3.1. Market size and forecast, by Type

7.5.5.3.2. Market size and forecast, by Application

7.5.5.3.3. Market size and forecast, by End User

7.5.5.4. South Africa

7.5.5.4.1. Market size and forecast, by Type

7.5.5.4.2. Market size and forecast, by Application

7.5.5.4.3. Market size and forecast, by End User

7.5.5.5. Rest of LAMEA

7.5.5.5.1. Market size and forecast, by Type

7.5.5.5.2. Market size and forecast, by Application

7.5.5.5.3. Market size and forecast, by End User

8.1. Introduction

8.2. Top winning strategies

8.3. Product Mapping of Top 10 Player

8.4. Competitive Dashboard

8.5. Competitive Heatmap

8.6. Top player positioning, 2022

9.1. Jungbunzlauer

9.1.1. Company overview

9.1.2. Key Executives

9.1.3. Company snapshot

9.2. Shandong Xinhong Pharmaceutical Co., Ltd.

9.2.1. Company overview

9.2.2. Key Executives

9.2.3. Company snapshot

9.3. Shandong Fuyuan Bio-Tech CO.LTD.

9.3.1. Company overview

9.3.2. Key Executives

9.3.3. Company snapshot

9.4. Merck Millipore Corporation

9.4.1. Company overview

9.4.2. Key Executives

9.4.3. Company snapshot

9.5. Shaoxing Marina Biotechnology Co.Ltd.

9.5.1. Company overview

9.5.2. Key Executives

9.5.3. Company snapshot

9.6. Shandong Baisheng Biotechnology Co., Ltd.

9.6.1. Company overview

9.6.2. Key Executives

9.6.3. Company snapshot

9.7. Roquette Freres

9.7.1. Company overview

9.7.2. Key Executives

9.7.3. Company snapshot

9.8. Functional Food chem International Corporation

9.8.1. Company overview

9.8.2. Key Executives

9.8.3. Company snapshot

9.9. Hubei Yitai Pharmaceutical Co.Ltd.

9.9.1. Company overview

9.9.2. Key Executives

9.9.3. Company snapshot

9.10. Anhui Fubore Pharmaceutical & Chemical Co.Ltd.

9.10.1. Company overview

9.10.2. Key Executives

9.10.3. Company snapsho

LIST OF TABLES

TABLE 01. GLOBAL GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)

TABLE 02. GLUCURONOLACTONE MARKET FOR POWDER, BY REGION, 2022-2032 ($THOUSAND)

TABLE 03. GLUCURONOLACTONE MARKET FOR LIQUID, BY REGION, 2022-2032 ($THOUSAND)

TABLE 04. GLUCURONOLACTONE MARKET FOR TABLET/CAPSULE, BY REGION, 2022-2032 ($THOUSAND)

TABLE 05. GLOBAL GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)

TABLE 06. GLUCURONOLACTONE MARKET FOR PRESERVATIVES, BY REGION, 2022-2032 ($THOUSAND)

TABLE 07. GLUCURONOLACTONE MARKET FOR ANTIOXIDANTS, BY REGION, 2022-2032 ($THOUSAND)

TABLE 08. GLUCURONOLACTONE MARKET FOR PROCESSING AIDS AND ADDITIVES, BY REGION, 2022-2032 ($THOUSAND)

TABLE 09. GLUCURONOLACTONE MARKET FOR ENERGY SUPPLEMENTS, BY REGION, 2022-2032 ($THOUSAND)

TABLE 10. GLOBAL GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)

TABLE 11. GLUCURONOLACTONE MARKET FOR FOOD AND BEVERAGES, BY REGION, 2022-2032 ($THOUSAND)

TABLE 12. GLUCURONOLACTONE MARKET FOR PHARMACEUTICALS, BY REGION, 2022-2032 ($THOUSAND)

TABLE 13. GLUCURONOLACTONE MARKET, BY REGION, 2022-2032 ($THOUSAND)

TABLE 14. NORTH AMERICA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)

TABLE 15. NORTH AMERICA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)

TABLE 16. NORTH AMERICA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)

TABLE 17. NORTH AMERICA GLUCURONOLACTONE MARKET, BY COUNTRY, 2022-2032 ($THOUSAND)

TABLE 18. U.S. GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)

TABLE 19. U.S. GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)

TABLE 20. U.S. GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)

TABLE 21. CANADA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)

TABLE 22. CANADA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)

TABLE 23. CANADA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)

TABLE 24. MEXICO GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)

TABLE 25. MEXICO GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)

TABLE 26. MEXICO GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)

TABLE 27. EUROPE GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)

TABLE 28. EUROPE GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)

TABLE 29. EUROPE GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)

TABLE 30. EUROPE GLUCURONOLACTONE MARKET, BY COUNTRY, 2022-2032 ($THOUSAND)

TABLE 31. GERMANY GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)

TABLE 32. GERMANY GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)

TABLE 33. GERMANY GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)

TABLE 34. UK GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)

TABLE 35. UK GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)

TABLE 36. UK GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)

TABLE 37. FRANCE GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)

TABLE 38. FRANCE GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)

TABLE 39. FRANCE GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)

TABLE 40. SPAIN GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)

TABLE 41. SPAIN GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)

TABLE 42. SPAIN GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)

TABLE 43. ITALY GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)

TABLE 44. ITALY GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)

TABLE 45. ITALY GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)

TABLE 46. REST OF EUROPE GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)

TABLE 47. REST OF EUROPE GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)

TABLE 48. REST OF EUROPE GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)

TABLE 49. ASIA-PACIFIC GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)

TABLE 50. ASIA-PACIFIC GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)

TABLE 51. ASIA-PACIFIC GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)

TABLE 52. ASIA-PACIFIC GLUCURONOLACTONE MARKET, BY COUNTRY, 2022-2032 ($THOUSAND)

TABLE 53. CHINA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)

TABLE 54. CHINA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)

TABLE 55. CHINA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)

TABLE 56. JAPAN GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)

TABLE 57. JAPAN GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)

TABLE 58. JAPAN GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)

TABLE 59. INDIA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)

TABLE 60. INDIA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)

TABLE 61. INDIA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)

TABLE 62. SOUTH KOREA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)

TABLE 63. SOUTH KOREA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)

TABLE 64. SOUTH KOREA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)

TABLE 65. AUSTRALIA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)

TABLE 66. AUSTRALIA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)

TABLE 67. AUSTRALIA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)

TABLE 68. REST OF ASIA-PACIFIC GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)

TABLE 69. REST OF ASIA-PACIFIC GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)

TABLE 70. REST OF ASIA-PACIFIC GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)

TABLE 71. LAMEA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)

TABLE 72. LAMEA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)

TABLE 73. LAMEA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)

TABLE 74. LAMEA GLUCURONOLACTONE MARKET, BY COUNTRY, 2022-2032 ($THOUSAND)

TABLE 75. BRAZIL GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)

TABLE 76. BRAZIL GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)

TABLE 77. BRAZIL GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)

TABLE 78. SAUDI ARABIA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)

TABLE 79. SAUDI ARABIA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)

TABLE 80. SAUDI ARABIA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)

TABLE 81. UNITED ARAB EMIRATES GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)

TABLE 82. UNITED ARAB EMIRATES GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)

TABLE 83. UNITED ARAB EMIRATES GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)

TABLE 84. SOUTH AFRICA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)

TABLE 85. SOUTH AFRICA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)

TABLE 86. SOUTH AFRICA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)

TABLE 87. REST OF LAMEA GLUCURONOLACTONE MARKET, BY TYPE, 2022-2032 ($THOUSAND)

TABLE 88. REST OF LAMEA GLUCURONOLACTONE MARKET, BY APPLICATION, 2022-2032 ($THOUSAND)

TABLE 89. REST OF LAMEA GLUCURONOLACTONE MARKET, BY END USER, 2022-2032 ($THOUSAND)

TABLE 90. JUNGBUNZLAUER: KEY EXECUTIVES

TABLE 91. JUNGBUNZLAUER: COMPANY SNAPSHOT

TABLE 92. SHANDONG XINHONG PHARMACEUTICAL CO., LTD.: KEY EXECUTIVES

TABLE 93. SHANDONG XINHONG PHARMACEUTICAL CO., LTD.: COMPANY SNAPSHOT

TABLE 94. SHANDONG FUYUAN BIO-TECH CO.LTD.: KEY EXECUTIVES

TABLE 95. SHANDONG FUYUAN BIO-TECH CO.LTD.: COMPANY SNAPSHOT

TABLE 96. MERCK MILLIPORE CORPORATION: KEY EXECUTIVES

TABLE 97. MERCK MILLIPORE CORPORATION: COMPANY SNAPSHOT

TABLE 98. SHAOXING MARINA BIOTECHNOLOGY CO.LTD.: KEY EXECUTIVES

TABLE 99. SHAOXING MARINA BIOTECHNOLOGY CO.LTD.: COMPANY SNAPSHOT

TABLE 100. SHANDONG BAISHENG BIOTECHNOLOGY CO., LTD.: KEY EXECUTIVES

TABLE 101. SHANDONG BAISHENG BIOTECHNOLOGY CO., LTD.: COMPANY SNAPSHOT

TABLE 102. ROQUETTE FRERES: KEY EXECUTIVES

TABLE 103. ROQUETTE FRERES: COMPANY SNAPSHOT

TABLE 104. FUNCTIONAL FOOD CHEM INTERNATIONAL CORPORATION: KEY EXECUTIVES

TABLE 105. FUNCTIONAL FOOD CHEM INTERNATIONAL CORPORATION: COMPANY SNAPSHOT

TABLE 106. HUBEI YITAI PHARMACEUTICAL CO.LTD.: KEY EXECUTIVES

TABLE 107. HUBEI YITAI PHARMACEUTICAL CO.LTD.: COMPANY SNAPSHOT

TABLE 108. ANHUI FUBORE PHARMACEUTICAL & CHEMICAL CO.LTD.: KEY EXECUTIVES

TABLE 109. ANHUI FUBORE PHARMACEUTICAL & CHEMICAL CO.LTD.: COMPANY SNAPSHOT LIST OF FIGURES

FIGURE 01. GLUCURONOLACTONE MARKET, 2022-2032

FIGURE 02. SEGMENTATION OF GLUCURONOLACTONE MARKET,2022-2032

FIGURE 03. TOP INVESTMENT POCKETS IN GLUCURONOLACTONE MARKET (2023-2032)

FIGURE 04. BARGAINING POWER OF SUPPLIERS

FIGURE 05. BARGAINING POWER OF BUYERS

FIGURE 06. THREAT OF SUBSTITUTION

FIGURE 07. THREAT OF SUBSTITUTION

FIGURE 08. COMPETITIVE RIVALRY

FIGURE 09. GLOBAL GLUCURONOLACTONE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES

FIGURE 10. REGULATORY GUIDELINES: GLUCURONOLACTONE MARKET

FIGURE 11. IMPACT OF KEY REGULATION: GLUCURONOLACTONE MARKET

FIGURE 12. PATENT ANALYSIS BY COMPANY

FIGURE 13. PATENT ANALYSIS BY COUNTRY

FIGURE 14. GLUCURONOLACTONE MARKET, BY TYPE, 2022 AND 2032(%)

FIGURE 15. COMPARATIVE SHARE ANALYSIS OF GLUCURONOLACTONE MARKET FOR POWDER, BY COUNTRY 2022 AND 2032(%)

FIGURE 16. COMPARATIVE SHARE ANALYSIS OF GLUCURONOLACTONE MARKET FOR LIQUID, BY COUNTRY 2022 AND 2032(%)

FIGURE 17. COMPARATIVE SHARE ANALYSIS OF GLUCURONOLACTONE MARKET FOR TABLET/CAPSULE, BY COUNTRY 2022 AND 2032(%)

FIGURE 18. GLUCURONOLACTONE MARKET, BY APPLICATION, 2022 AND 2032(%)

FIGURE 19. COMPARATIVE SHARE ANALYSIS OF GLUCURONOLACTONE MARKET FOR PRESERVATIVES, BY COUNTRY 2022 AND 2032(%)

FIGURE 20. COMPARATIVE SHARE ANALYSIS OF GLUCURONOLACTONE MARKET FOR ANTIOXIDANTS, BY COUNTRY 2022 AND 2032(%)

FIGURE 21. COMPARATIVE SHARE ANALYSIS OF GLUCURONOLACTONE MARKET FOR PROCESSING AIDS AND ADDITIVES, BY COUNTRY 2022 AND 2032(%)

FIGURE 22. COMPARATIVE SHARE ANALYSIS OF GLUCURONOLACTONE MARKET FOR ENERGY SUPPLEMENTS, BY COUNTRY 2022 AND 2032(%)

FIGURE 23. GLUCURONOLACTONE MARKET, BY END USER, 2022 AND 2032(%)

FIGURE 24. COMPARATIVE SHARE ANALYSIS OF GLUCURONOLACTONE MARKET FOR FOOD AND BEVERAGES, BY COUNTRY 2022 AND 2032(%)

FIGURE 25. COMPARATIVE SHARE ANALYSIS OF GLUCURONOLACTONE MARKET FOR PHARMACEUTICALS, BY COUNTRY 2022 AND 2032(%)

FIGURE 26. GLUCURONOLACTONE MARKET BY REGION, 2022 AND 2032(%)

FIGURE 27. U.S. GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)

FIGURE 28. CANADA GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)

FIGURE 29. MEXICO GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)

FIGURE 30. GERMANY GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)

FIGURE 31. UK GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)

FIGURE 32. FRANCE GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)

FIGURE 33. SPAIN GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)

FIGURE 34. ITALY GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)

FIGURE 35. REST OF EUROPE GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)

FIGURE 36. CHINA GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)

FIGURE 37. JAPAN GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)

FIGURE 38. INDIA GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)

FIGURE 39. SOUTH KOREA GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)

FIGURE 40. AUSTRALIA GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)

FIGURE 41. REST OF ASIA-PACIFIC GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)

FIGURE 42. BRAZIL GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)

FIGURE 43. SAUDI ARABIA GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)

FIGURE 44. UNITED ARAB EMIRATES GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)

FIGURE 45. SOUTH AFRICA GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)

FIGURE 46. REST OF LAMEA GLUCURONOLACTONE MARKET, 2022-2032 ($THOUSAND)

FIGURE 47. TOP WINNING STRATEGIES, BY YEAR

FIGURE 48. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 49. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 50. PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 51. COMPETITIVE DASHBOARD

FIGURE 52. COMPETITIVE HEATMAP: GLUCURONOLACTONE MARKET

FIGURE 53. TOP PLAYER POSITIONING, 202